{"id":"https://openalex.org/W7225310017","doi":"https://doi.org/10.3389/fphar.2026.1998984","title":"Informing the development of \u03b2-lactam\u2014\u03b2-lactamase inhibitor combinations through a comparison of in vitro data","display_name":"Informing the development of \u03b2-lactam\u2014\u03b2-lactamase inhibitor combinations through a comparison of in vitro data","publication_year":2026,"publication_date":"2026-11-05","ids":{"openalex":"https://openalex.org/W7225310017","doi":"https://doi.org/10.3389/fphar.2026.1998984"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2026.1998984","doi":"https://doi.org/10.3389/fphar.2026.1998984","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1998984","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1998984/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1998984/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065205827","display_name":"Elissar Mansour","orcid":"https://orcid.org/0000-0002-5645-1105","observed_orcids":["https://orcid.org/0000-0002-5645-1105"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Elissar Mansour","raw_affiliation_strings":["Sydney Pharmacy School, The University of Sydney"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sydney Pharmacy School, The University of Sydney","institution_ids":["https://openalex.org/I129604602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084264345","display_name":"Jonathan J. Du","orcid":"https://orcid.org/0000-0002-7750-4413","observed_orcids":["https://orcid.org/0000-0002-7750-4413"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Jonathan J. Du","raw_affiliation_strings":["Sydney Pharmacy School, The University of Sydney"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sydney Pharmacy School, The University of Sydney","institution_ids":["https://openalex.org/I129604602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071553375","display_name":"Mohamed Far\u00e8s","orcid":"https://orcid.org/0000-0003-0589-3955","observed_orcids":["https://orcid.org/0000-0003-0589-3955"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Mohamed Fares","raw_affiliation_strings":["Sydney Pharmacy School, The University of Sydney"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sydney Pharmacy School, The University of Sydney","institution_ids":["https://openalex.org/I129604602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088845547","display_name":"David E. Hibbs","orcid":"https://orcid.org/0000-0002-2635-2990","observed_orcids":["https://orcid.org/0000-0002-2635-2990"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"David E. Hibbs","raw_affiliation_strings":["Sydney Pharmacy School, The University of Sydney"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sydney Pharmacy School, The University of Sydney","institution_ids":["https://openalex.org/I129604602"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067632543","display_name":"Paul W. Groundwater","orcid":"https://orcid.org/0000-0002-4932-2030","observed_orcids":["https://orcid.org/0000-0002-4932-2030"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Paul W. Groundwater","raw_affiliation_strings":["Sydney Pharmacy School, The University of Sydney"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sydney Pharmacy School, The University of Sydney","institution_ids":["https://openalex.org/I129604602"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5067632543"],"corresponding_institution_ids":["https://openalex.org/I129604602"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/beta-lactam-antibiotics","display_name":"beta-lactam antibiotics","score":0.8769999742507935},{"id":"https://openalex.org/keywords/beta-lactamase-inhibitors","display_name":"beta-lactamase inhibitors","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-antibiotic-therapy","display_name":"combination antibiotic therapy","score":0.5429999828338623},{"id":"https://openalex.org/keywords/antimicrobial-resistance","display_name":"antimicrobial resistance","score":0.8539999723434448},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.6290000081062317},{"id":"https://openalex.org/keywords/antibacterial-drug-development","display_name":"antibacterial drug development","score":0.6050000190734863}],"concepts":[{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.5006999969482422},{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.4765999913215637},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.47209998965263367},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4578999876976013},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3822000026702881},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37119999527931213},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.3391999900341034},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.3246999979019165},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3174999952316284},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.31189998984336853},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.29350000619888306},{"id":"https://openalex.org/C2909960733","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial drug","level":3,"score":0.29120001196861267},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.28060001134872437},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.27160000801086426},{"id":"https://openalex.org/C2993778972","wikidata":"https://www.wikidata.org/wiki/Q1201508","display_name":"Antibacterial peptide","level":4,"score":0.26460000872612},{"id":"https://openalex.org/C33618052","wikidata":"https://www.wikidata.org/wiki/Q6013136","display_name":"In vitro toxicology","level":3,"score":0.2623000144958496},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.2563000023365021},{"id":"https://openalex.org/C2778883795","wikidata":"https://www.wikidata.org/wiki/Q804517","display_name":"Pathogenic bacteria","level":3,"score":0.2531000077724457}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.3389/fphar.2026.1998984","doi":"https://doi.org/10.3389/fphar.2026.1998984","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1998984","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1998984/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:daee5f8d8f404f079fa980926f17cc6f","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/daee5f8d8f404f079fa980926f17cc6f","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2026.1998984","doi":"https://doi.org/10.3389/fphar.2026.1998984","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1998984","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1998984/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225310017.pdf","grobid_xml":"https://content.openalex.org/works/W7225310017.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W1541916960","https://openalex.org/W1979973356","https://openalex.org/W1980433906","https://openalex.org/W2039287878","https://openalex.org/W2087416539","https://openalex.org/W2102368355","https://openalex.org/W2145456994","https://openalex.org/W2168072235","https://openalex.org/W2216041545","https://openalex.org/W2594303706","https://openalex.org/W2884470329","https://openalex.org/W2918470083","https://openalex.org/W2956936996","https://openalex.org/W3016888373","https://openalex.org/W3092849554","https://openalex.org/W3130309548","https://openalex.org/W4200393513","https://openalex.org/W4296639073","https://openalex.org/W4296803705","https://openalex.org/W4313559257","https://openalex.org/W4389346069","https://openalex.org/W4394566934","https://openalex.org/W4400112692","https://openalex.org/W4400850656","https://openalex.org/W4402557213","https://openalex.org/W4414027208","https://openalex.org/W4414062309","https://openalex.org/W4414902728","https://openalex.org/W7116108199"],"related_works":["https://openalex.org/W2918608884","https://openalex.org/W4392887207","https://openalex.org/W2129772896","https://openalex.org/W2972950834","https://openalex.org/W3046173670","https://openalex.org/W2407151623","https://openalex.org/W2081886178","https://openalex.org/W2767436702","https://openalex.org/W2061769703","https://openalex.org/W3106009346"],"abstract_inverted_index":{"Mortality":[0],"rates":[1],"associated":[2],"with":[3],"antimicrobial":[4],"resistance":[5],"are":[6,13,84,114],"increasing":[7],"at":[8],"an":[9,53],"alarming":[10],"rate":[11],"and":[12,90],"becoming":[14],"one":[15],"of":[16,29,38,52,67,78,97,105,131,136],"the":[17,27,45,49,58,63,75,79,92,103,110,132,137],"most":[18],"serious":[19],"threats":[20],"to":[21,47,61,73,109],"global":[22],"health.":[23],"Paradoxically,":[24],"investment":[25],"in":[26,57,123,133,143],"development":[28,96],"new":[30,154],"antibacterial":[31,54],"agents":[32],"is":[33],"limited":[34],"as":[35,147],"a":[36,129,148],"result":[37],"multiple":[39],"factors,":[40],"including":[41],"resistance,":[42],"which":[43],"have":[44,70],"potential":[46],"shorten":[48],"clinical":[50,124],"lifespan":[51],"agent.":[55],"Improvements":[56],"tools":[59],"used":[60],"predict":[62],"success":[64],"or":[65],"failure":[66],"drug":[68,80],"candidates":[69],"been":[71],"shown":[72],"reduce":[74],"overall":[76],"cost":[77],"discovery":[81],"process.":[82],"\u03b2-Lactamases":[83],"drug-modifying":[85],"enzymes":[86],"that":[87],"can":[88,101],"hydrolyse":[89],"inactivate":[91],"\u03b2-lactam":[93],"antibiotics.":[94],"The":[95],"\u03b2-lactamase":[98],"inhibitors":[99],"(BLIs)":[100],"enable":[102],"re-sensitisation":[104],"bacteria":[106],"previously":[107],"resistant":[108],"\u03b2-lactams":[111],"(BLs).":[112],"There":[113],"nine":[115,138],"\u03b2-lactam/\u03b2-lactamase":[116],"inhibitor":[117],"(BL/BLI)":[118],"combinations":[119,142],"available":[120],"for":[121,151],"use":[122],"practice.":[125],"This":[126],"review":[127],"presents":[128],"summary":[130],"vitro":[134],"performance":[135],"currently":[139],"marketed":[140],"BL/BLI":[141],"synergy":[144],"assays,":[145],"serving":[146],"comparative":[149],"reference":[150],"researchers":[152],"developing":[153],"combinations.":[155]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-06T00:00:00"}